Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[volixibat]
(D11006)
[1] Volixibat[2] Volixibat potassium (D11006),
Volixibat 💬
--[1] 93 💬
2Volixibat
(D11006)
[1] Volixibat[2] Volixibat potassium (D11006),
Volixibat 💬
--[2] 93, 94 💬
3Volixibat (formely SHP626, LUM002 or SAR548304B)
(D11006)
[1] Volixibat[2] Volixibat potassium (D11006),
Volixibat 💬
--[1] 94 💬
4Volixibat potassium
(D11006)
[2] Potassium,
Volixibat
[3] Potassium ,
Volixibat potassium (D11006),
Volixibat 💬
--[2] 93, 94 💬
5VolixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: volixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use
(D11006)
[1] Volixibat[2] Volixibat potassium (D11006),
Volixibat 💬
--[1] 93 💬